No Detail Found!

Management and assessment of indeterminate (U3) thyroid nodules: A5-year multisite retrospective study

Author(s)
Ravi Patel Department of Trauma and Orthopaedics, The Princess Royal Hospital, Apley Castle, Telford, TF1 6TF- United Kingdom; Department of Trauma and Orthopaedics, Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry- United Kingdom
Alison Conybeare Department of Otorhinolaryngology, The Princess Royal Hospital, Apley Castle, Telford-United Kingdom
Harrypal Panesar Department of Otorhinolaryngology, The Princess Royal Hospital, Apley Castle, Telford-United Kingdom
Sara Badrol Department of Otorhinolaryngology, The Princess Royal Hospital, Apley Castle, Telford-United Kingdom
Salil Sood Department of Otorhinolaryngology, The Princess Royal Hospital, Apley Castle, Telford-United Kingdom
Abstract
Background: The U grading of Ultrasound scan (USS) is used to assess the likelihood of malignancy in a thyroid nodule and help determine those that warrant an FNAC confirmation. All those of a U3-5 warrant an FNAC for confirmation and typing. This study aims to review the follow-up practice and the likelihood of picking up a malignancy on subsequent USS and FNAC, for those determined as a n indeterminate U3 nodule. Methods: We retrospective reviewed the trust database (Portal) for patients who had a U3 nodule reported on USS identified, and clinical, operative and outcomes data were analysed. Results: 258 scans were identified over a 5-year period. The average age was 59 (range 1595) years old at first USS with a female to the male sex ratio of 4:1. The average number of USS that each patient prior to final diagnosis had averaged at 2.8 (range 1 -12). Of those with an initial Thy status, 64 (33%) were benign (Thy2) and a further 49 (25%) were nondiagnostics (Thy1). Over time, only 7 nodules were upgraded to a potential malignancy. Of those who underwent surgery, a final histological diagnosis was obtained in 41 cases. Only Thy1, 2 and 3f produced benign final histology results. Conclusion: For those indeterminate (U3) nodules of Th1-3f, electing for a watch and wait management strategy is reasonable for up to 2.5 years and 4 follow-up scans at an interval of 6-12 months should be implemented. A Thy2 result on a U3 nodule should not be taken as completely reassuring, a high index of suspicion of malignancy must be maintained.
Publication Details
Page(s) 216-219
Published Journal: Journal of Ayub Medical College, Volume: 35, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Thyroid nodule, US scan, Diagnostic imaging, Fine-needle aspiration cytology
0

Citations

0

Downloads

106

Views